Neulbit Kim brings nine years of biopharmaceutical experience to his role as Senior Scientist in Facility Monitoring. Since joining the company in 2017, he has led multiple equipment validation and system qualification projects. He has been an integral member of several facility start‑up task forces, shaping Samsung Biologics’ monitoring strategies. Neulbit’s core expertise lies in biomanufacturing quality control, and he currently oversees the comprehensive management of quality records. This includes deviation investigations, out‑of‑trend (OOT) events, corrective and preventive actions (CAPAs), and change‑control documentation, ensuring strict adherence to GMP and regulatory requirements.
